This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
ISPAD Clinical Science School in Mexico City 3-4 February 2017

ISPAD Clinical Science School
Mexico City - February, 2017

This ISPAD Diabetes Education Program, providing a Clinical Science Update on Pediatric Diabetes, attracted nearly 100 physicians from Mexico. Attendees heard numerous lectures related to standards of care and new approaches to optimizing the biomedical and psychosocial outcomes of pediatric, adolescent and young adult patients living with diabetes. The course, funded by an unrestricted educational grant from Medtronic, was convened by Dr. Lori Laffel, Chief of the Pediatric, Adolescent and Young Adult Section at the Joslin Diabetes Center and Professor of Pediatrics at Harvard Medical School in Boston, and co-convened by Dr. Ana Lilia Rodríguez Ventura, Pediatric Endocrinologist and Professor in the Faculty of Medicine of Mexico City, Hospital Infantil Privado Star Médica. In addition, other faculty members included Dr. Joseph Wolfsdorf, current president of ISPAD, Director of the Diabetes Program at Boston Children’s Hospital, and Professor of Pediatrics at Harvard Medical School and Dr. Ingrid Libman, Director of the Pediatric Diabetes Program at the Children’s Hospital of Pittsburgh and Associate Professor of Pediatrics and Epidemiology at the University of Pittsburgh Medical Center.

The first course day included a full curriculum covering topics such as diagnosing and treating pediatric diabetes using intensive management approaches, dietary and exercise management, diabetes sick day management, prevention and management of type 2 diabetes in youth, evaluation and management of comorbidities and complications associated with diabetes, update on diabetes technologies, optimizing psychosocial outcomes, and transitions in care from pediatrics to adult diabetes services. The second day of the conference began with an outstanding overview of up-to-date approaches to closed-loop insulin delivery by Dr. Thomas Danne, past president of ISPAD and Head of the Pediatric Diabetes Program and Professor of Pediatrics at Hannover Medical School. This was followed by an extensive panel discussion involving the core faculty members along with Dr. Danne and local Mexican pediatric endocrinologist Dr. Carlos Antillón with many questions and comments from the audience. The conference attracted Mexican physicians,  including pediatric and adult specialists and general physicians involved in the care of pediatric, adolescent, and young adult patients with diabetes.

The faculty witnessed extraordinary audience engagement throughout the conference, related to the review of standards of care as well as innovative approaches to maximizing health outcomes and quality of life for young patients living with diabetes. ISPAD is grateful for the educational grant from Medtronic and looks forward to similar initiatives in other areas around the globe.

Contact Us

ISPAD Executive Office
c/o K.I.T. Group GmbH
Association & Conference Management
Kurfürstendamm 71
10709 Berlin, Germany


Click the link below to join the Society!

Join Today!

Phone: +49 (0)30 24603-210
Fax: +49 (0)30 24603-200
Email: secretariat@ispad.or

Privacy Policy
Terms of Service
Legal Notice    


 © 2020 International Society for Pediatric and Adolescent Diabetes (ISPAD)

Association Management Software Powered by YourMembership  ::  Legal